🇺🇸 Alogliptin and pioglitazone in United States

FDA authorised Alogliptin and pioglitazone on 25 January 2013

Marketing authorisations

FDA — authorised 25 January 2013

  • Application: NDA022426
  • Marketing authorisation holder: TAKEDA PHARMS USA
  • Status: supplemented

FDA

  • Status: approved

Alogliptin and pioglitazone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Alogliptin and pioglitazone approved in United States?

Yes. FDA authorised it on 25 January 2013; FDA has authorised it.

Who is the marketing authorisation holder for Alogliptin and pioglitazone in United States?

TAKEDA PHARMS USA holds the US marketing authorisation.